Home/Filings/4/0001161697-21-000587
4//SEC Filing

Bosua Phillip 4

Accession 0001161697-21-000587

CIK 0001074828other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 9:07 AM ET

Size

10.4 KB

Accession

0001161697-21-000587

Insider Transaction Report

Form 4
Period: 2021-12-16
Bosua Phillip
DirectorCEO and President10% Owner
Transactions
  • Award

    Option to Purchase Common Stock

    2021-12-16+1,300,0001,300,000 total
    Exercise: $2.09Exp: 2026-12-15Common Stock (1,300,000 underlying)
Holdings
  • Option to Purchase Common Stock

    Exercise: $1.28Exp: 2023-08-01Common Stock (1,000,000 underlying)
    1,000,000
  • Option to Purchase Common Stock

    Exercise: $1.10Exp: 2024-11-04Common Stock (1,200,000 underlying)
    1,200,000
  • Option to Purchase Common Stock

    Exercise: $1.53Exp: 2025-12-15Common Stock (4,264,395 underlying)
    4,264,395
  • Common Stock

    3,005,000
Footnotes (4)
  • [F1]Option shares vest 25% quarterly over four years beginning 08/01/2018.
  • [F2]Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.
  • [F3]Milestone-based Option shares vest upon the Company's successful milestone achievements set forth in two Stock Option Agreements dated 12/15/2020.
  • [F4]Options vest quarterly over four years. Immediate vesting upon the occurrence of a Change-in-Control.

Issuer

KNOW LABS, INC.

CIK 0001074828

Entity typeother

Related Parties

1
  • filerCIK 0001738153

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 9:07 AM ET
Size
10.4 KB